Pfizer making a killing off jabs

Pfizer making a killing off jabs

It is curious to me that so little is being done to question these conflicts of interest between the symbiotic Big Pharma-Big Government complex, which is pushing the needles into so many arms.

So I am digging a little more into it. If you "follow the money", you just might find some "open secrets". Ah, open secrets dot org. A quick perusal of some of their stuff reveals something of a pinko bias, but it does have an interesting bit of info about lobbying that may be of interest to curious types.

The Covid 19 "vaccine" has been very good for a number of fat-cats. All of the jab makers are having great years. Big business has been very good for the commies. But open secrets dot org isn't likely to tell you that in that way. But look who is in power now and how they got there. Not that the GOP is any better. A deeper dive into this may yield some interesting information about Chinese money. ( But I haven't found anything like that yet, but when I do...)

Pfizer lobbied the CDC for approval of its "vaccine", according to the link above. The very thought of that seems corrupt.

Open Secrets article

Pfizer's full FDA approval could lead to even greater profits

by Melissa Holzberg and Tara Souter

August 24 2021

Partially reproduced

Ahead of Monday’s announcement from the Food and Drug Administration that the department would grant full approval of the Pfizer-BioNTec COVID-19 vaccine, Pfizer had already reported a blockbuster year of profits from its vaccine. Now with full FDA approval, plus authorization for a third booster dose, Pfizer could see even greater revenue.

Pfizer reported $5.6 billion in net income during the second quarter of 2021 — that’s up more than $2 billion (from $3.5 billion) from its second quarter of 2020 report to the Securities and Exchange Commission. In the first half of 2021, Pfizer reported nearly $10.5 billion in net income. The company brought in $6.9 billion in the first six months of 2020.

As the pharmaceutical company’s income and reputation have skyrocketed from bringing the first COVID-19 vaccine to market, the company’s lobbying efforts have increased as well. In 2020, Pfizer spent $13.2 million on its lobbying efforts — that’s up from $11 million in 2019 and the most the company has spent on lobbying since 2009 during the debate over the Affordable Care Act.

The company was the second highest spender in the pharmaceutical and health products industry, with Pharmaceutical Research & Manufacturers of America spending more than $25.9 million on lobbying efforts in 2020. So far, Pfizer has spent $6.7 million on lobbying efforts in 2021, the same pace the company set in 2020. Pfizer spent much of 2020 lobbying the Centers for Disease Control and Prevention and the FDA while the two departments weighed recommending and authorizing its vaccine for emergency use.

In Pfizer’s latest SEC disclosure, the company reported $7.8 billion in total revenue from its COVID-19 vaccine in the second quarter. Pfizer disclosed a total of $11.3 billion in COVID-19 vaccine revenue in the first half of 2021. While this revenue can’t be compared to any other year on record, since the vaccine was only first administered under the FDA’s emergency use authorization in Dec. 2020, Pfizer’s COVID-19 vaccine has provided more revenue than any other Pfizer vaccine on the market. The company reported $14.1 billion total revenue from its vaccine programs in the first half of 2021. Just under $3 billion of that is coming from other Pfizer vaccines for diseases including pneumococcal disease, tick-borne encephalitis disease and meningococcal disease.

In the first six months of 2020 — before any COVID-19 vaccine was authorized for emergency use — Pfizer reported just $2.9 billion in total revenue from its vaccine programs. According to the SEC filing, revenue from the U.S. government represented “12% and 14% of total revenues for the three and six month” periods in 2021. And those sales were “primarily” Pfizer’s COVID-19 vaccine. Want first access to OpenSecrets' investigations and data features? Learn about Article Alert. With full FDA approval, the company can now also market its vaccine directly to consumers.

Under the FDA’s emergency use authorization, Pfizer had to rely on the government’s agencies to spread the word about its vaccine. The other two authorized COVID-19 vaccines, made by Moderna and Johnson & Johnson, have also seen revenue boosts from their vaccine programs but haven’t caught up to Pfizer’s success. In Moderna’s second quarter SEC filing, the company reported a net income of nearly $2.8 billion. During the second quarter of 2020, Moderna reported a loss of $117 million. In total, the pharmaceutical company has generated $4 billion of net income in 2021. Moderna’s total product revenue from its COVID-19 vaccine was $4.2 billion in the second quarter of 2021, and $5.9 billion for the first half of the year.

Its COVID-19 vaccine is the first product the company has brought to market and therefore doesn’t have a comparable revenue in 2020. In 2020, Moderna spent just $280,000 on lobbying efforts and the company has spent $290,000 so far on lobbying in 2021. Johnson & Johnson, which is a larger company than both Pfizer and Moderna with more products on the market, reported a booming net income of $6.3 billion in the second quarter of 2021, and $12.5 billion in the first half of 2021. However, the company reported just $164 million in sales of its one-dose COVID-19 vaccine in the second quarter, and $264 million in the first half of the year.

Johnson & Johnson spent $5.6 million on lobbying efforts in 2020, and has already spent about $3.3 million on lobbying in 2021. While the FDA has only granted full approval for Pfizer’s vaccine, Moderna applied for full approval in June. Currently Pfizer’s vaccine is still under emergency use authorization for adolescents between the ages of 12 and 15, and Moderna and Johnson & Johnson are authorized for people 18 and older. By granting full approval, the FDA cleared the way for more agencies and companies to mandate COVID-19 vaccinations. After Monday’s announcement, the Pentagon said it will require all active-duty U.S. military members to receive the COVID-19 vaccination. And New York City public schools — the largest public school system in the country — will now require all faculty and staff to be vaccinated with no COVID-19 testing alternative.

Last week, President Joe Biden announced the Department of Health and Human Services will begin offering booster shots on Sept. 20, eight months after a person’s second dose of either the Pfizer or Moderna vaccines. The CDC also recommended a third dose of the Pfizer and Moderna vaccines to immunocompromised individuals to be administered earlier than the eight month guideline for the rest of the population. Feel free to distribute or cite this material, but please credit OpenSecrets.